Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsNatco pharma

    Natco Pharma

    Jump to

    • Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y

    • Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y

    • Natco Pharma shares fall post 7 observations from USFDA

      Natco Pharma Share Price | On conclusion of the inspection, the company received seven observations from USFDA.

    • Stocks to Watch Today: TCS, Rail Vikas Nigam, Tata Power, HG Infra, Natco Pharma, Lupin, Shilpa Medicare, IDBI Bank in focus on 24 November

      Stocks to Watch, 24 November: Stocks like Tata Consultancy Services, Rail Vikas Nigam, Tata Power Company, HG Infra Engineering, Kalpataru Projects International, Natco Pharma, Lupin, Shilpa Medicare, IDBI Bank, Kotak Mahindra Bank, Tata Chemicals, Samavardhana Motherson International, and RNIT AI Solutions will be in focus on November 24.

    • Reduce Natco Pharma: target of Rs 750: ICICI Securities

      ICICI Securities recommended reduce rating on Natco Pharma with a target price of Rs 750 in its research report dated November 15, 2025.

    • Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y

    • Natco Pharma shares fall 3.5% as SC agrees to urgently list Roche's plea on Risdiplam launch

      Roche moved the apex court after Delhi High Court allowed Natco Pharma to launch Risdiplam drug

    • Natco Pharma shares jump 6% after Delhi HC allows firm to sell 'Risdiplam' in India

      Natco Pharma share price: The shares of the company have jumped more than 8% in the past six months, but have dropped nearly 40% in 2025 so far.

    • Stocks to Watch Today: TCS, Tata Elxsi, Natco Pharma, WeWork, Afcons Infra, Lloyds Engineering, NTPC Green Energy, 5Paisa Capital in focus on 10 October

      Stocks to Watch, 10 October: Tata Consultancy Services, Tata Elxsi, 5Paisa Capital, ICICI Prudential Life Insurance Company, Afcons Infrastructure, Lloyds Engineering Works, NTPC Green Energy, RailTel Corporation of India, Natco Pharma, TechEra Engineering, and WeWork India Management will be in focus on October 10.

    • Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y

    • Stocks to Watch Today: Infosys, Dr Reddys Labs, Tata Consumer, Cigniti, Force Motors, Natco Pharma, IndusInd Bank, BEML, Tilaknagar Ind in focus on 24 July

      Stocks to Watch, 24 July: Stccks like Infosys, Dr Reddys Laboratories, Tata Consumer Products, Cigniti Technologies, Force Motors, Natco Pharma, IndusInd Bank, BEML, and Tilaknagar Industries will be in focus on July 24.

    • Natco Pharma offers to buy 35.75% stake in South Africa's Adcock Ingram for Rs 2,000 crore

      Natco Pharma to set up arm in South Africa with investment of Rs 2,100 crore

    • Natco Pharma plans to acquire majority stake in South Africa-based Adcock Ingram Holdings: CNBC-Awaaz

      Adcock Ingram offers generics and OTC medicines in Africa. CNBC-Awaaz reported that Natco may buy majority stake in the firm

    • Natco Pharma shares fall on seven observations from USFDA

      Natco Pharma share price | The USFDA concluded the inspection at company's unit at Kothur, Hyderabad, India with seven observations.

    • Stocks to Watch Today: Sai Life Sciences, Kaynes Tech, GMM Pfaudler, Axiscades Tech, Natco Pharma, ITD Cementation, Oswal Pumps in focus on 20 June

      Stocks to Watch, 20 June: Stocks like Brigade Enterprises, TD Power Systems, JSW Infrastructure, Biocon, United Spirits, Can Fin Homes, Container Corporation of India, Sai Life Sciences, Kaynes Technology India, GMM Pfaudler, Axiscades Technologies, ITD Cementation India, Natco Pharma, and Le Travenues Technology will be in focus on June 20.

    • Stocks to Watch Today: ITC, Bajaj Finance, Sun Pharmaceutical, Syngene, Natco Pharma, Vedanta, Sacheerome in focus on 16 June

      Stocks to watch, 16 June: Gujarat Themis Biosyn, Godrej Properties, Sun Pharmaceutical Industries, Belrise Industries, Syngene International, Natco Pharma, Vedanta, ITC, Eicher Motors, South Indian Bank, NTPC, Nazara Technologies, Scoda Tubes, Shalby, Jubilant Pharmova, Jubilant Foodworks, and Jubilant Ingrevia will be in focus on June 16.

    • Natco Pharma Standalone March 2025 Net Sales at Rs 1,157.40 crore, up 19.96% Y-o-Y

    • Natco Pharma Consolidated March 2025 Net Sales at Rs 1,221.00 crore, up 14.29% Y-o-Y

    • Hold Natco Pharma; target of Rs 890: ICICI Securities

      ICICI Securities recommended hold rating on Natco Pharma with a target price of Rs 890 in its research report dated May 30, 2025.

    • Stocks to Watch Today: SAIL, Avanti Feeds, Insecticides India, Balaji Amines, Cummins, Mishra Dhatu Nigam, IRCTC, Unified Data Tech in focus on 29 May

      Stocks to watch, 29 May: Stocks like Bharat Rasayan, HeidelbergCement India, Birlasoft,Som Distilleries and Breweries, Natco Pharma, Deepak Nitrite, RITES, Aurobindo Pharma, IndusInd Bank, Steel Authority of India, Avanti Feeds, Insecticides India, Balaji Amines, Cummins India, ITC, ADF Foods, Mishra Dhatu Nigam, and Unified Data Tech Solutions will be in focus on May 29.

    • Natco Pharma Consolidated December 2024 Net Sales at Rs 474.80 crore, down 37.41% Y-o-Y

    • Natco Pharma Standalone December 2024 Net Sales at Rs 407.60 crore, down 34.82% Y-o-Y

    • Natco Pharma shares bleed 18.5% as Q3 earnings show disappoints

      Natco Pharma's Q3 earnings were heavily dented by a sharp drag in its export formulations segment, which accounted for 44 percent of its total sales.

    • Natco Pharma Consolidated September 2024 Net Sales at Rs 1,371.10 crore, up 32.94% Y-o-Y

    • Natco Pharma Standalone September 2024 Net Sales at Rs 1,292.60 crore, up 38.91% Y-o-Y

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347